ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1165408 Boston, MA

Position in KYMR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,934,000

-$4,968,150 QoQ

Shares Held

200,000

-40.3% QoQ

Ownership

0.241%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#53

of 273 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. KYMR ranks #48 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	10,349,328	$366,262,717
2	PRAX	Praxis Precision Medicines, Inc.	1,015,480	$339,972,549
3	VRTX	Vertex Pharmaceuticals Inc / Ma	393,964	$195,693,737
4	TNGX	Tango Therapeutics, Inc.	5,600,000	$175,056,000
5	BBIO	BridgeBio Pharma, Inc.	2,252,000	$167,728,960
6	SYRE	Spyre Therapeutics, Inc.	1,722,300	$152,905,794
7	TVTX	Travere Therapeutics, Inc.	2,569,356	$145,965,114
8	RPRX	Royalty Pharma plc	2,500,000	$140,175,000

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,934,000	200,000	-40.3%	Shares	Sole	2026-08-14
2026-03-31	$27,902,150	335,000	-22.1%	Shares	Sole	2026-05-15
2025-12-31	$33,458,300	430,000	+80.7%	Shares	Sole	2026-02-17
2025-09-30	$13,470,800	238,000	-21.8%	Shares	Sole	2025-11-14
2025-06-30	$13,275,288	304,200	+69.0%	Shares	Sole	2025-08-14
2022-03-31	$7,617,600	180,000	-12.2%	Shares	Sole	2022-05-16
2021-12-31	$13,015,450	205,000	-18.0%	Shares	Sole	2022-02-14
2021-09-30	$14,685,000	250,000	+150.0%	Shares	Sole	2021-11-15
2021-06-30	$4,850,000	100,000	0.0%	Shares	Sole	2021-08-16
2021-03-31	$3,886,000	100,000	0.0%	Shares	Sole	2021-05-17
2020-12-31	$6,200,000	100,000	-60.0%	Shares	Sole	2021-02-16
2020-09-30	$8,077,500	250,000	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.